Logo image of ESON.LS

ESTORIL SOL SGPS SA-REG SHS (ESON.LS) Stock Fundamental Analysis

ELI:ESON - PTESO0AM0000 - Common Stock

4.1 EUR
+0.14 (+3.54%)
Last: 8/27/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, ESON scores 2 out of 10 in our fundamental rating. ESON was compared to 0 industry peers in the Unkown industry. While ESON seems to be doing ok healthwise, there are quite some concerns on its profitability. ESON is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ESON had negative earnings in the past year.
In the past year ESON had a positive cash flow from operations.
Of the past 5 years ESON 4 years were profitable.
Of the past 5 years ESON 4 years had a positive operating cash flow.
ESON.LS Yearly Net Income VS EBIT VS OCF VS FCFESON.LS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M

1.2 Ratios

The 3 year average ROIC (13.45%) for ESON is well above the current ROIC(3.34%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -2.48%
ROE -6.68%
ROIC 3.34%
ROA(3y)9.62%
ROA(5y)3.75%
ROE(3y)14.71%
ROE(5y)5.57%
ROIC(3y)13.45%
ROIC(5y)N/A
ESON.LS Yearly ROA, ROE, ROICESON.LS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20 -20

1.3 Margins

In the last couple of years the Profit Margin of ESON has declined.
ESON's Operating Margin has improved in the last couple of years.
In the last couple of years the Gross Margin of ESON has remained more or less at the same level.
Industry RankSector Rank
OM 10.01%
PM (TTM) N/A
GM 98.16%
OM growth 3YN/A
OM growth 5Y1.99%
PM growth 3YN/A
PM growth 5Y-18.34%
GM growth 3Y-0.1%
GM growth 5Y0.24%
ESON.LS Yearly Profit, Operating, Gross MarginsESON.LS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60 80

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ESON is creating some value.
ESON has about the same amout of shares outstanding than it did 1 year ago.
The number of shares outstanding for ESON remains at a similar level compared to 5 years ago.
Compared to 1 year ago, ESON has an improved debt to assets ratio.
ESON.LS Yearly Shares OutstandingESON.LS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
ESON.LS Yearly Total Debt VS Total AssetsESON.LS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

ESON has an Altman-Z score of 0.99. This is a bad value and indicates that ESON is not financially healthy and even has some risk of bankruptcy.
The Debt to FCF ratio of ESON is 0.29, which is an excellent value as it means it would take ESON, only 0.29 years of fcf income to pay off all of its debts.
ESON has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Although ESON does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.29
Altman-Z 0.99
ROIC/WACC0.38
WACC8.84%
ESON.LS Yearly LT Debt VS Equity VS FCFESON.LS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

ESON has a Current Ratio of 1.62. This is a normal value and indicates that ESON is financially healthy and should not expect problems in meeting its short term obligations.
ESON has a Quick Ratio of 1.43. This is a normal value and indicates that ESON is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.43
ESON.LS Yearly Current Assets VS Current LiabilitesESON.LS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

ESON shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -135.34%.
The earnings per share for ESON have been decreasing by -16.29% on average. This is quite bad
ESON shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.21%.
The Revenue has been growing slightly by 2.52% on average over the past years.
EPS 1Y (TTM)-135.34%
EPS 3YN/A
EPS 5Y-16.29%
EPS Q2Q%-194.48%
Revenue 1Y (TTM)-14.21%
Revenue growth 3Y17.83%
Revenue growth 5Y2.52%
Sales Q2Q%-12.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ESON.LS Yearly Revenue VS EstimatesESON.LS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ESON. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ESON.LS Price Earnings VS Forward Price EarningsESON.LS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 27.85
EV/EBITDA N/A
ESON.LS Per share dataESON.LS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ESON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ESTORIL SOL SGPS SA-REG SHS

ELI:ESON (8/27/2025, 7:00:00 PM)

4.1

+0.14 (+3.54%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.13%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap49.16M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.3
Dividend Growth(5Y)18.43%
DP-145.2%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.43
P/FCF 27.85
P/OCF 1.93
P/B 0.41
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.66
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.15
FCFY3.59%
OCF(TTM)2.13
OCFY51.88%
SpS9.49
BVpS9.88
TBVpS-5.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.48%
ROE -6.68%
ROCE 4.23%
ROIC 3.34%
ROICexc 4.49%
ROICexgc 50.66%
OM 10.01%
PM (TTM) N/A
GM 98.16%
FCFM 1.55%
ROA(3y)9.62%
ROA(5y)3.75%
ROE(3y)14.71%
ROE(5y)5.57%
ROIC(3y)13.45%
ROIC(5y)N/A
ROICexc(3y)48.44%
ROICexc(5y)N/A
ROICexgc(3y)112.04%
ROICexgc(5y)N/A
ROCE(3y)17.45%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y29.92%
ROICexc growth 3YN/A
ROICexc growth 5Y-19.41%
OM growth 3YN/A
OM growth 5Y1.99%
PM growth 3YN/A
PM growth 5Y-18.34%
GM growth 3Y-0.1%
GM growth 5Y0.24%
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.29
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 20.85%
Interest Coverage 250
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.43
Altman-Z 0.99
F-Score4
WACC8.84%
ROIC/WACC0.38
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)12.27%
Cap/Sales(5y)7.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-135.34%
EPS 3YN/A
EPS 5Y-16.29%
EPS Q2Q%-194.48%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.21%
Revenue growth 3Y17.83%
Revenue growth 5Y2.52%
Sales Q2Q%-12.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-64.59%
EBIT growth 3YN/A
EBIT growth 5Y4.56%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-95.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.71%
OCF growth 3YN/A
OCF growth 5Y-2.54%